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OBJECTIVES: This study aimed to measure the association between the adiponectin, C1Q and collagen domain-
containing (ADIPOQ) gene variants and obesity in Koreans.
METHODS: Three single nucleotide polymorphisms located in the ADIPOQ gene were genotyped in a popu-
lation-based cross-sectional study of 986 healthy Koreans. Three different case-control groups (i.e. G1, G2, and 
G3) were defined according to body mass index (BMI) and serum adiponectin levels. Allelic and genotypic as-
sociations of this gene with obesity were measured using multivariate logistic regression analyses in each group.
RESULTS: The G allele of -11377C>G, a polymorphism located in the promoter region of the ADIPOQ gene 
(odds ratio (OR), 1.48; 95% confidence interval, 1.13-1.94) and most haplotypes including this allele signifi-
cantly increased the risk for obesity. However, the OR decreased from 3.98 (G1 group) to 2.90 (G2 group) and 
2.30 (G3 group) when a less strict definition of obesity was used. Most haplotypes, including this allele, signifi-
cantly increased the risk of obesity. The statistical evidence from the GG genotype of -11377C>G (OR, 3.98) 
and the GT/GT diplotype composed of -11377G>C and +45T>G (OR, 5.20) confirmed the contribution of 
the G allele toward a predisposition for obesity.
CONCLUSION: These results suggest the contribution of the ADIPOQ gene toward susceptibility to obesity 
in healthy Koreans. The high-risk genotypes and haplotypes identified here may provide more information for 
identifying individuals who are at risk of obesity.
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INTRODUCTION
Obesity is a prevalent condition and a modifiable risk factor 
for various complex diseases, including diabetes and cardiovas-
cular disease. Although the current World Health Organization 
(WHO) definitions for being overweight and obesity are body 
mass index (BMI) of ≥25-29.9 kg/m2 and ≥30 kg/m2, respec-
tively, different BMI cut-off points of 23-24.9 kg/m2 and ≥25 
kg/m2, respectively, were suggested for the Asian population 
[1,2]. In Korea, the prevalence of obesity (BMI ≥25 kg/m2) has 
dramatically increased over the past decade and the third Ko-
rea National Health & Nutrition Examination Survey reported 
that the overall prevalence of obesity in Korean adults was 
30.6% (29.4% in women and 32.4% in men) in 2001 [3].
Adiponectin decreases body weight by increasing lipid oxida-
tion in muscles and other organs such as the pancreas and liver 
[4]. The concentration of adiponectin in plasma was shown to 
be negatively correlated with BMI [5]. In humans, adiponectin 
is encoded by portions of exons 2 and 3 among the three exons 
of the adiponectin, C1Q and collagen domain-containing (ADI-
POQ) gene (also denoted as APM1 or ACDC) located on chro-
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mosome 3q27 [6]. The 13 single nucleotide polymorphisms 
(SNPs) in the ADIPOQ gene were previously reported in Japa-
nese and French populations [7]. Two SNPs located on exon 2 
(+45T>G, a synonymous mutation, Gly15Gly) and intron 2 
(+276G>T) of the ADIPOQ gene were reported to be associ-
ated with both plasma adiponectin concentrations and type 2 
diabetes (T2D) in Japanese, German, and Italian populations 
[7-9]. The G allele of the SNP -11377C>G located in the pro-
moter region was also shown to be associated with lower adi-
ponectin levels and severe obesity among Danish women [10]. 
Neither the mechanism responsible for controlling the synthe-
sis of adiponectin nor the regulation of ADIPOQ gene expres-
sion have been fully determined as yet. The effect of the ADI-
POQ gene on the risk of obesity may vary according to ethnic-
ity, age, and he degree of obesity across populations [11].
Thus, this study aimed to perform an analysis of the associa-
tion between the ADIPOQ gene and BMI, an index of obesity, 
whilst considering plasma adiponectin levels in a Korean popu-
lation. We defined three groups of two extremes for comparison 
according to a combination of BMI levels and plasma adiponec-
tin concentrations after adjusting for age and sex in 986 healthy 
Koreans.
MATERIALS AND METHODS
Study subjects
The study population consisted of 10,169 subjects who had 
participated in routine health examinations at the Health Pro-
motion Center, Yonsei University Severance Hospital during 
the period of April 2006 to July 2008. The analyses excluded 
subjects with any disease, including diabetics (with fasting se-
rum glucose ≥126 mg/dL), and those with prior usage of lipid-
lowering drugs, as well as all participants with missing informa-
tion on BMI or adiponectin levels. Finally, 986 subjects, aged 
21 to 81 yr old, were genotyped for subsequent analyses. The 
Institutional Review Board of Human Research of Yonsei Uni-
versity approved the study, and written informed consent was 
obtained from all subjects before participation.
Data collection
Each participant was interviewed using a structured question-
naire to collect histories of cigarette smoking (non-smoker, ex-
smoker, or current smoker) and alcohol consumption (non-drin-
ker or any alcohol drinker), as well as other demographic char-
acteristics such as age and gender. The weight and height of each 
participant were measured in light clothing. The BMI was calcu-
lated as weight (kg) divided by height squared (m2).
Measurement of biomarkers
For the clinical chemistry assay, serum was separated from 
peripheral venous blood samples obtained from each partici-
pant after 12 hr of fasting and stored at -70°C. Biomarkers for 
metabolic syndrome, such as fasting blood glucose, were mea-
sured using a Hitachi-7600 analyzer (Hitachi Ltd., Tokyo, Japan). 
The adiponectin level was measured using an enzyme-linked 
immunosorbent assay (ELISA; B-Bridge International Inc., 
Sunnyvale, CA, USA). Data quality control was performed in 
accordance with the procedures of the Korean Association of 
Laboratory Quality Control.
Genotyping of SNPs
Genomic DNA was isolated from lymphocytes by using a 
DNA isolation kit according to the protocol of the manufactur-
er (WIZARD Genomic DNA purification kit; Promega Corp., 
Madison, WI, USA). In several populations other than Korean, 
three SNPs in the ADIPOQ gene were found to be associated 
with the levels of adiponectin and obesity [11]. Thus, the SNPs 
-11377C>G (rs266729), +45T>G (rs2241766), and +276G>T 
(rs1501299) were genotyped using the SNP-IT™ (SNP-Identi-
fication Technology) assay with the SNPstream 25K® System 
(Orchid Biosciences, Princeton, NJ, USA), as previously descri-
bed [12]. The development of blue and/or yellow colors corre-
sponding to two alleles was analyzed with an ELISA reader 
and the final genotype calling was made by the QC Review™ 
program (Orchid Biosciences). The genotyping success rate was 
an average of 99.12% and four duplicates of control DNA on 
each plate showed a 99% consistency rate for the genotype 
calling.
Statistical analysis
Analysis of variance (ANOVA) was used to evaluate whether 
these three SNPs were associated with plasma adiponectin con-
centration and BMI. Variations in these SNPs were significantly 
associated with adiponectin level and BMI (data not shown). 
Although obesity was not defined according to the WHO defi-
nition (i.e. a BMI of 25 kg/m2 or higher for Asians) in this study, 
obesity is known to positively correlate with BMI and reversely 
correlate with the level of adiponectin, and the ADIPOQ gene 
is the gene of interest as a susceptibility gene of obesity [13]. 
Therefore, we divided our study subjects into five groups (quin-
tiles) of BMI (<22.7, 22.7-24.1, 24.2-25.4, 25.5-26.9, and ≥27.0 
kg/m2 for men and <21.2, 21.2-22.8, 22.9-24.0, 24.1-25.5, and 
≥25.6 kg/m2 for women) and five groups of adiponectin (<3.7, 
3.8-4.7, 4.8-6.0, 6.1-7.9, and ≥8.0 μg/mL for men and <5.6, 
5.6-7.1, 7.2-9.1, 9.2-12.1, and ≥12.2 μg/mL for women), re-
spectively. We then defined three different comparison groups 
according to both the level of BMI and the plasma adiponectin 
concentration to compare obese individuals versus slim indi-
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viduals, as shown in Figure 1 (i.e. G1, G2, and G3).
The minor allele frequency (MAF) and a chi-square test for 
the Hardy-Weinberg equilibrium (HWE) at each SNP, and the 
pair-wise linkage disequilibrium (LD) by both D´ and r2 were 
computed among the controls of the G3 group using the Hap-
loview program [14]. In order to measure the risk of obesity for 
alleles and genotypes of individual SNPs, as well as for haplo-
types and diplotypes composed of two or three SNPs, multiple 
logistic regression models were tested in each of the three com-
parison groups after adjusting for age and other potential con-
founding factors such as gender, smoking status, and alcohol 
consumption. Genotypic odds ratios (GORs) and 95% confi-
dence intervals (95% CIs) for heterozygotes and homozygotes 
were calculated separately, and then the best genetic model for 
each marker was determined using the Stata version 9.0 (Stata-
Corp, College Station, TX, USA). To determine whether an in-
significant result observed in the genotypic test was caused by 
a type II error, the power was computed using the web browser 
‘Genetic Power Calculator’ [15].
RESULTS
As shown in Table 1, 73.1% of the study population was com-
posed of men (with a mean age of 49.5 yr old), and 26.9% of 
the population was female (mean: 51.2 yr old). The average 
BMI values were 24.8 and 23.6 kg/m2 for men and women, re-
spectively. The plasma adiponectin level was approximately 30% 
higher in women (9.1 μg/mL) than in men (6.2 μg/mL). No gen-
der difference was observed in the homeostasis model assess-
ment of insulin resistance (HOMA-IR) levels. As shown Figure 
1, the numbers of cases and controls increased from G1 (55 cas-
es, 71 controls) to G3 (259 cases, 272 controls).
The major alleles for each marker of -11377C>G, +45T>G, 
and +276G>T in the controls of the G3 group were C, T, and G, 
respectively. All three markers showed sufficient heterozygosity, 
and no evidence of deviation from HWE was observed in any 
marker (Table 2). Three SNPs were not found to be in strong 
linkage disequilibrium based on the values of r2. Although indi-
viduals with the GG genotype of -11377C>G had a higher 
BMI and lower adiponectin concentration (25.1 kg/m2 and 6.7 
μg/mL) compared to individuals with the CC reference geno-
type (24.4 kg/m2 and 7.1 μg/mL), the difference was not statis-
tically significant (p=0.09) (Table 3).
Allelic and genotypic odds ratios for individual SNPs
As shown in Table 4, the G allele and the GG genotype of the 
-11377C>G SNP significantly increased the risk of obesity 
(OR, 1.48 and 2.30, respectively, in the G3 group), although the 
regression model for the genotypic test was marginally signifi-
G1 G2 G3
Adiponectin
Q1 Q2 Q3 Q4 Q5
BM
I
Q5
Q4
Q3
Q2
Q1
55 cases: BMI Q5 & Adipo Q1*
71 control: BMI Q1 & Adipo Q5
Adiponectin
Q1 Q2 Q3 Q4 Q5
BM
I
Q5
Q4
Q3
Q2
Q1
131 cases: BMI Q4-Q5 & Adipo Q1- Q2
160 controls: BMI Q1-Q2 & Adipo Q4-Q5
Adiponectin
Q1 Q2 Q3 Q4 Q5
BM
I
Q5
Q4
Q3
Q2
Q1
259 cases: BMI Q3-Q5 & Adipo Q1-Q3
272 controls: BMI Q1-Q3 & Adipo Q3-Q5
Figure 1. Case and control definitions by both body mass index (BMI) and plasma adiponectin concentration.
Q, stands for quintile.
Table 1. Characteristics of the study population
Variables Categories Men(n=711)
Women
(n=275)
Mean±SD Mean±SD
Age (yr)
Weight (kg)
Height (cm)
Body mass index (kg/m2)
Adiponectine (μg/mL)
Insulin (IU/mL)
49.5±9.8
71.6±9.5
169.7±5.9
24.8±2.7
6.2±3.3
3.4±1.8
51.2±10.4
57.6±7.0
156.4±5.4
23.6±2.7
9.1±4.7
3.6±2.2
% %
Smoking status Non-smokers
Ex-smokers
Current smokers
18.7
38.0
43.3
92.4
2.8
3.8
Alcohol consumption Non-drinkers
Any alcohol drinkers
31.1
68.9
81.8
18.2
SD, standard deviation.
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Table 2. Marker information for three SNPs located in the ADIPOQ gene (3q27)
SNP Physicalposition
Location
in ADPOQ
Alleles*
MAF† HWE (p)
D´\r 2‡
1 2 M1 M2 M3
-11377C>G 188042168 5’-2 kb C G 0.24 0.60 - 0.83 0.06
45T>G 188053586 exon T G 0.28 0.24 0.08 - 1
276G>T 188053817 intron G T 0.28 0.61 0 0.14 -
MAF, minor allele frequency; HWE, Hardy-Weinberg equilibrium; D: above the di agonal; r 2, below the diagonal.
*Major alleles are in bold type; †Minor allele frequencies measured among controls of G3; ‡Pair-wise LD was computed as both D´ and r 2.
Table 3. Variations in BMI (kg/mg2) and adiponectin concentration (μg/mL) by genotype of the three SNPs
SNP Genotype n BMI (Mean±SE) Adiponectin (Mean±SE)
-11377C>G CC
CG
GG
p-value
534
373
79
24.42±0.12
24.43±0.14
25.09±0.30
0.09
7.10±0.16
6.89±0.19
6.71±0.42
0.28
45T>G TT
GT
GG
p-value
533
372
81
24.46±0.12
24.52±0.14
24.34±0.30
0.91
7.00±0.16
6.90±0.19
7.69±0.42
0.26
276G>T GG
GT
TT
p-value
501
395
90
24.38±0.12
24.57±0.14
24.58±0.28
0.52
6.94±0.17
7.16±0.19
6.70±0.40
0.53
BMI, body mass index; SE, standard error.
p-values are adjusted for age and sex.
Table 4. Risk estimations for alleles and genotypes of individual markers by three levels of BMI and adiponectin concentration
SNP
G1 G2 G3
Case Control OR (95% CI) Case Control OR (95% CI) Case Control OR (95% CI)
-11377C>G C
G
72
38
109
 33
Reference
1.73 (0.99-3.02)
180
 82
242
 78
Reference
1.43 (0.99-2.06)
356
162
416
128
Reference
1.48 (1.13-1.94)
45T>G T
G
86
24
100
 42
Reference
0.64 (0.36-1.14)
204
 58
241
 79
Reference
0.86 (0.58-1.27)
401
117
394
150
Reference
0.78 (0.59-1.03)
276G>T G
T
77
33
111
 31
Reference
1.57 (0.89-2.80)
179
 83
236
 84
Reference
1.33 (0.92-1.90)
351
167
393
151
Reference
1.23 (0.95-1.61)
-11377C>G
CC
GC
GG
27
18
10
 42
 25
  4
p=0.13
Reference
1.05 (0.48-2.33)
3.98 (1.12-14.14)
 68
 44
 19
 91
 60
  9
p=0.09
Reference
0.99 (0.60-1.64)
2.90 (1.23-6.83)
129
 98
 32
161
 94
 17
p=0.06
Reference
1.32 (0.91-1.91)
2.30 (1.22-4.34)
45T>G
TT
GT
GG
32
22
 1
 40
 20
 11
p=0.03
Reference
1.35 (0.62-2.92)
0.10 (0.01-0.86)
 78
 48
  5
 96
 49
 15
p=0.24
Reference
1.20 (0.73-1.97)
0.40 (0.14-1.16)
154
 93
 12
147
100
 25
p=0.23
Reference
0.90 (0.62-1.29)
0.47 (0.23-0.97)
276G>T
GG
GT
TT
30
17
 8
 43
 25
  3
p=0.18
Reference
1.00 (0.46-2.17)
4.03 (0.97-16.65)
 63
 53
 15
 90
 56
 14
p=0.48
Reference
1.36 (0.83-2.23)
1.61 (0.72-3.58)
122
107
 30
144
105
 23
p=0.47
Reference
1.19 (0.83-1.71)
1.54 (0.85-2.80)
BMI, body mass index; OR, odds ratio; CI, confidence interval.
ORs are adjusted for age and sex and 95% CI.
p-values are calculated by logistic regression models.
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cant (p=0.06). However, the OR decreased as the number of 
subjects increased (i.e. when the less strict definition of obesity 
was used) from 3.98 (group G1) to 2.90 (group G2) and 2.30 
(group G3). The GG homozygotes of +45T>G showed a signif-
icantly low OR of 0.10, but only one case and eleven controls 
were available in the G1 group. The TT homozygotes of +276G 
>T were found to increase the risk of obesity, but this finding 
was not statistically significant. A recessive mode of inheritance 
was the best-fit to our data for all three markers in the most ex-
treme comparison group of obesity (i.e. the G1 group) (data not 
shown). To test whether or not the number of subjects was suf-
ficient to detect the effect size for each genotype, we modeled 
our study power under a recessive mode of inheritance. The G3 
group composed of 259 cases and 272 controls achieved 80% 
power to significantly detect the OR over 2.29 and 2.06 under 
the assumption of disease prevalence, 30%; and disease allele 
frequencies, 0.24 and 0.28, respectively. In the current study, 
the ADIPOQ gene variants did not show a consistent trend of 
increasing or decreasing obesity for age. For instance, the ORs 
of the -11377C>G GG genotype were 2.4, 4, and 1.34 for the 
case-control groups less than 45 yr old (composed of 91 cases 
and 91 controls), 45-54 yr old (98 cases and 100 controls), and 
greater than 55 yr of age (83 cases and 68 controls), respective-
ly, in the case of the G3 group.
Haplotype and diplotype odds ratios for two or three 
SNPs
As shown in Table 5, the GT haplotype composed of the risk 
alleles of both SNPs -11377C>G and +45T>G significantly 
increased the risk of obesity in the G3 group (OR, 1.65; 95% 
CI, 1.17-2.32). Although the OR for the GG haplotype was sig-
nificantly high (OR=4.02), the number of subjects was not suf-
ficient. In Model 2, the CT and GG haplotypes consisted of one 
risky allele of either -11377C>G or +276G>T that significant-
ly increased the risk of obesity (i.e. OR, 2.87 and 3, respective-
ly, in the G1 group), whereas the GT haplotype consisted of two 
risky alleles that moderately increased the risk of obesity only 
in the G3 group (OR, 1.52; 95% CI, 1.03-2.25). In Model 3, the 
risk of obesity among those with the GTG haplotype was three-
fold higher compared to the reference group in G1, whereas it 
decreased to 1.87 (1.20-2.91) in the G3 group. With two and 
three markers there were three and seven marker combinations, 
respectively (i.e. 2n-1) for which a haplotype-based test could 
be carried out. Even without considering the LD between the 
markers, the multiple comparison levels of significance for hap-
lotypes consisting of two and three SNPs were 0.017 and 7×  
10-3, respectively. The GT (p=0.004), GG (p=0.006) and GTG 
haplotypes (p=0.005) in each model for the G3 group were 
significant even after the Bonferroni correction. The GG haplo-
type in Model 2 also yielded a Bonferroni level of significance 
in both G1 (p=0.003) and G2 groups (p=0.013).
The increased risk as the number of risky alleles increased in 
diplotypes of two SNPs, -11377C>G and +45T>G (i.e. OR, 
2.96, 3.54, and 5.20 for CG/CT, CT/GT, and GT/GT, respec-
tively), confirmed the contributions of the G and T alleles of 
each SNP in predisposing toward obesity (table not shown). 
Table 5. Risk estimation for 2-3 SNP haplotypes showing statistical significance by three levels of BMI and adiponectin concentration*
SNP G1 G2 G3
-11377C>G 45T>G 276G>T Case Control OR (95% CI) Case Control OR (95% CI) Case Control OR (95% CI)
Model 1
C
C
G
G
 
G
T
G
T
 
22
50
 2
36
 
42
67
 0
33
p=0.09
Reference
1.50 (0.79-2.86)
-
2.13 (1.05-4.32)
 
 55
125
  3
 79
 
 79
163
  0
 78
p=0.23
Reference
1.11 (0.73-1.68)
-
1.48 (0.93-2.36)
 
108
248
  9
153
 
147
269
  3
125
p=0.01
Reference
1.24 (0.91-1.67)
4.02 (1.06-15.21)
1.65 (1.17-2.32)
Model 2
C
C
G
G
 
G
T
G
T
 
51
21
26
12
 
95
14
16
17
p=3.6×10-3
Reference
2.87 (1.34-6.16)
3.00 (1.46-6.15)
1.31 (0.58-2.99)
 
128
 52
 51
 31
 
193
 49
 43
 35
p=0.04
Reference
1.62 (1.03-2.55)
1.80 (1.13-2.86)
1.37 (0.80-2.35)
 
256
100
 95
 67
 
320
 96
 73
 55
p=0.03
Reference
1.30 (0.94-1.79)
1.62 (1.15-2.30)
1.52 (1.03-2.25)
Model 3
C
C
C
C
G
G
G
 
G
G
T
T
G
G
T
 
G
T
G
T
G
T
G
 
31
 6
20
15
 9
 0
17
 
52
 1
43
13
 6
 3
10
p=6.6×10-3
Reference
11.52 (1.31-101.22)
0.81 (0.40-1.64)
1.97 (0.82-4.73)
2.35 (0.75-7.35)
-
2.98 (1.19-7.41)
 
 71
 17
 57
 35
 16
  2
 35
 
101
  8
 92
 41
 13
  6
 30
p=0.04
Reference
3.11 (1.27-7.62)
0.88 (0.56-1.37)
1.22 (0.71-2.11)
1.70 (0.77-3.77)
0.44 (0.09-2.26)
1.69 (0.95-3.01)
 
138
 33
118
 67
 31
  8
 64
 
184
 26
136
 70
 28
 12
 45
p<0.05
Reference
1.68 (0.96-2.94)
1.14 (0.82-1.59)
1.26 (0.84-1.88)
1.48 (0.85-2.58)
0.88 (0.35-2.22)
1.87 (1.20-2.91)
OR, odds ratio; CI, confidence interval.
ORs are adjusted for age and sex. 
*Model composed of 2 SNPs: 45T>G and 276G>T were not significant.
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This result also showed that the mutant alleles of two SNPs, 
-11377C>G and +276G>T, increased the risk of obesity wher-
eas the G allele of +45T>G was protective.
DISCUSSION
In the present study, three SNPs located on the ADIPOQ 
gene, which have previously been studied for an association 
with obesity in other ethnic groups [16], were evaluated in heal-
thy Koreans. The C, T, and G alleles were the major alleles at 
SNPs -11377C>G, +45T>G, and +276G>T, respectively, as 
shown in other studies, including non-diabetic Japanese and 
non-diabetic Koreans [7,17]. A common allele, C, of -11377C>G 
was strongly associated with a lower plasma adiponectin level, 
a higher BMI, or T2D in some studies [18,19], whereas a rare 
allele, G, was associated with the same phenotypes in other 
studies [10,20]. Similar trends toward inconsistent results across 
studies were observed for the +45T>G and +276G>T loci. 
The rare G allele at the +45T>G locus significantly increased 
the risk of obesity in non-diabetic Germans and in Japanese 
with T2D [7,8], while Loos et al. [21] recently reported that 
carriers of the rare GG homozygote showed a leaner pheno-
type than carriers of the common T allele. The G allele at the 
+276G>T locus was associated with lower plasma adiponectin 
concentrations and higher insulin resistance only in subjects 
with a high BMI (≥26.7) in non-diabetic Korean and Japanese 
populations [7,17]. Homozygotes for the haplotype T45-G276 
had a higher body weight and waist circumference and lower 
plasma adiponectin concentrations in non-diabetic Italians and 
non-diabetic obese Koreans [17,22,23].
In our study, the G allele of SNP -11377C>G (OR, 1.48; 95% 
CI, 1.13-1.94) and the T allele at the +45T>G locus were iden-
tified as being risk alleles for obesity, even after issues of study 
power and multiple testing were taken into account, where obe-
sity was defined using both a higher BMI and a lower adipo-
nectin concentration compared to the reference group. The T al-
lele of the +276G>T locus was not statistically significant, but 
it increased the risk of obesity. Possible explanations for these 
inconsistent results across the studies include not only differen-
ces in population characteristics (e.g. demographic, genetic, and 
environmental factors, diagnostic criteria, etc.) but also the pos-
sibility that the configurations of genotypes or hapolotypes were 
mixed up in some studies. Minor allele frequencies of each SNP 
were different even from Japanese HapMap data (e.g. 28.9% of 
Japanese HapMap data vs. 24% of data in the current study for 
the SNP -11377C>G). Therefore, more prospective studies of a 
better design are necessary to confirm the effects of each vari-
ant on the development of obesity [17, 24]. As shown in other 
Korean studies, linkage disequilibrium was not observed be-
tween SNPs -11377C>G, +45T>G or +276G>T, whereas two 
SNPs, +45T>G and +276G>T were in imperfect (r2=0.14) 
but complete linkage disequilibrium (D´=1) in our study [18,23].
Overall, a stricter definition of the phenotype increased the 
statistical power to detect evidence of an association in our 
study. Although significantly high ORs were observed in the 
CG haplotype of -11377G>C and +45T>G (OR, 4.02) and 
the GGT haplotype (OR, 11.52), these high ORs may have been 
the result of the relatively small sample size (Table 4). Our re-
sults replicated the reverse relationship between BMI and plas-
ma adiponectin (Table 3) and the association between ADI-
POQ gene variants and obesity previously reported, although 
this study did not describe a causal relationship, but associa-
tions (Tables 4, 5) [5,10].
Several potential limitations of our study should be mentioned. 
Firstly, BMI may not be a sufficient indicator for measuring the 
degree of obesity. Although regional differences in body fat af-
fect the risk of metabolic abnormalities, and althou gh ADIPOQ 
gene variants were suggested as modulating visceral fat accu-
mulation in some studies, other studies detected no association 
between ADIPOQ gene variants and BMI [20]. Thus, other mea-
surements of obesity such as the waist:hip ratio or waist circum-
ference [10,25] might be better measures of abdominal obesity 
in the Korean population. Secondly, there may also be some in-
teractions with other genes related to susceptibility to obesity. 
For instance, evidence for an interaction between SNPs in the 
promoters of ADIPOQ (-3971A>G) and ADIPOR1 (-3882T> 
C) was found [21]. Thirdly, the effects of environmental factors 
controlling the risk of obesity could not be evaluated in this 
study. Given the role of adiponectin in fatty acid oxidation, a 
reduction in plasma adiponectin levels may impact the ability 
to clear cellular adipose in obese individuals with an at-risk 
diplotype [20]. However, the effect of this risky polymorphism 
could be validly evaluated after controlling for environmental 
factors (e.g. physical activity, fried food intake, alcohol consump-
tion, etc.), clinical characteristics (e.g. serum C-reactive protein, 
total cholesterol HDL ratio, blood pressure, etc.), and ethnicity 
[22,26]. Finally, the positive associations found in this study 
were based on the comparison made between a group of high 
BMI and low adiponectin subjects versus a group of low BMI 
and high adiponectin subjects. Thus, the statistical evidence mi-
ght not reflect the effect of ADIPOQ gene variants on BMI and 
plasma adiponectin concentrations separately, but rather a joint 
consideration of both indices for obesity. Therefore, additional 
studies warrant validation of the relationship between the ADI-
POQ gene and obesity identified in this study.
In conclusion, the SNPs identified here (i.e. -11377C>G and 
+45T>G) may assist in identifying subjects who are at a great-
er risk of obesity among healthy Koreans. Such information may 
provide a chance for susceptible individuals to prevent obesity 
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and for obese individuals to determine a more efficient means of 
weight control. Furthermore, understanding the mechanisms by 
which obesity could be controlled would make it possible for us 
to better understand the metabolic complications of obesity.
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